1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of ANK1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of ANK1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of ANK1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ANK1 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1309620 6480464 Estradiol results in increased expression of ANK1 mRNA CTD PMID:20068009 17beta-estradiol multiple interactions ISO RGD:1320055 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of ANK1 mRNA CTD PMID:30165855 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1309620 6480464 2 more ... CTD PMID:27291303 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1320055 6480464 2 more ... CTD PMID:31675489 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ANK1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1309620 6480464 Tetrachlorodibenzodioxin results in increased expression of ANK1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ANK1 mRNA CTD PMID:28213091 2,4,6-tribromophenol decreases expression ISO RGD:1320055 6480464 2 more ... CTD PMID:31675489 2-butoxyethanol increases expression EXP 6480464 n-butoxyethanol results in increased expression of ANK1 mRNA CTD PMID:19812364 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1320055 6480464 tetrabromobisphenol A results in decreased expression of ANK1 protein CTD PMID:31675489 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1320055 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of ANK1 gene CTD PMID:31601247 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of ANK1 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression ISO RGD:1309620 6480464 Propylthiouracil results in decreased expression of ANK1 mRNA CTD PMID:24780913 aconitine increases expression ISO RGD:1309620 6480464 Aconitine results in increased expression of ANK1 protein CTD PMID:33236894 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of ANK1 mRNA CTD PMID:30807115 aflatoxin B1 increases methylation ISO RGD:1320055 6480464 Aflatoxin B1 results in increased methylation of ANK1 gene CTD PMID:27153756 aflatoxin B1 affects methylation ISO RGD:1320055 6480464 Aflatoxin B1 affects the methylation of ANK1 intron CTD PMID:30157460 Aflatoxin B2 alpha increases methylation ISO RGD:1320055 6480464 aflatoxin B2 results in increased methylation of ANK1 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1320055 6480464 Tretinoin results in increased expression of ANK1 mRNA CTD PMID:33167477 arsane affects methylation ISO RGD:1320055 6480464 Arsenic affects the methylation of ANK1 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1320055 6480464 Arsenic affects the methylation of ANK1 gene CTD PMID:25304211 benzo[a]pyrene increases mutagenesis ISO RGD:1320055 6480464 Benzo(a)pyrene results in increased mutagenesis of ANK1 gene CTD PMID:25435355 benzo[a]pyrene increases expression ISO RGD:1320055 6480464 Benzo(a)pyrene results in increased expression of ANK1 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:1320055 6480464 Benzo(a)pyrene affects the methylation of ANK1 3' UTR more ... CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:1320055 6480464 Benzo(a)pyrene results in increased methylation of ANK1 exon CTD PMID:27901495 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of ANK1 mRNA CTD PMID:21569818 , PMID:22228805 benzo[e]pyrene affects methylation ISO RGD:1320055 6480464 benzo(e)pyrene affects the methylation of ANK1 intron CTD PMID:30157460 beta-hexachlorocyclohexane increases expression EXP 6480464 beta-hexachlorocyclohexane results in increased expression of ANK1 mRNA CTD PMID:25270620 bisphenol A decreases expression ISO RGD:1309620 6480464 bisphenol A results in decreased expression of ANK1 mRNA CTD PMID:25181051 more ... bisphenol A affects methylation ISO RGD:1320055 6480464 bisphenol A affects the methylation of ANK1 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:1320055 6480464 bisphenol A results in decreased expression of ANK1 protein CTD PMID:31675489 calcitriol increases expression ISO RGD:1320055 6480464 Calcitriol results in increased expression of ANK1 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1320055 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ANK1 mRNA CTD PMID:21592394 carbamazepine affects expression ISO RGD:1320055 6480464 Carbamazepine affects the expression of ANK1 mRNA CTD PMID:25979313 CGP 52608 multiple interactions ISO RGD:1320055 6480464 CGP 52608 promotes the reaction [RORA protein binds to ANK1 gene] CTD PMID:28238834 chlordecone increases expression EXP 6480464 Chlordecone results in increased expression of ANK1 mRNA CTD PMID:33711761 cisplatin multiple interactions ISO RGD:1320055 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of ANK1 mRNA CTD PMID:27392435 cisplatin increases expression ISO RGD:1320055 6480464 Cisplatin results in increased expression of ANK1 mRNA CTD PMID:27392435 decabromodiphenyl ether decreases expression ISO RGD:1309620 6480464 decabromobiphenyl ether results in decreased expression of ANK1 mRNA CTD PMID:23640034 decabromodiphenyl ether decreases expression ISO RGD:1320055 6480464 decabromobiphenyl ether results in decreased expression of ANK1 protein CTD PMID:31675489 dexamethasone decreases expression ISO RGD:1309620 6480464 Dexamethasone results in decreased expression of ANK1 mRNA CTD PMID:20032058 dexamethasone multiple interactions ISO RGD:1309620 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of ANK1 mRNA] CTD PMID:20032058 dicrotophos increases expression ISO RGD:1320055 6480464 dicrotophos results in increased expression of ANK1 mRNA CTD PMID:28302478 dioxygen multiple interactions EXP 6480464 Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of ANK1 mRNA] CTD PMID:22629407 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of ANK1 mRNA CTD PMID:22629407 dorsomorphin multiple interactions ISO RGD:1320055 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1320055 6480464 Doxorubicin results in increased expression of ANK1 mRNA CTD PMID:28940058 , PMID:30031762 endosulfan decreases expression ISO RGD:1309620 6480464 Endosulfan results in decreased expression of ANK1 mRNA CTD PMID:29391264 ethanol multiple interactions EXP 6480464 Ethanol affects the expression of and affects the splicing of ANK1 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:1320055 6480464 Ethyl Methanesulfonate results in increased expression of ANK1 mRNA CTD PMID:23649840 etoposide increases expression ISO RGD:1320055 6480464 Etoposide results in increased expression of ANK1 mRNA CTD PMID:29397400 genistein decreases expression ISO RGD:1320055 6480464 Genistein results in decreased expression of ANK1 mRNA CTD PMID:16705744 genistein increases expression EXP 6480464 Genistein results in increased expression of ANK1 mRNA CTD PMID:32186404 genistein increases methylation ISO RGD:1309620 6480464 Genistein results in increased methylation of ANK1 gene CTD PMID:28505145 gentamycin decreases expression ISO RGD:1309620 6480464 Gentamicins results in decreased expression of ANK1 mRNA CTD PMID:22061828 lead(0) affects expression ISO RGD:1320055 6480464 Lead affects the expression of ANK1 mRNA CTD PMID:28903495 lead(0) affects methylation ISO RGD:1320055 6480464 Lead affects the methylation of ANK1 gene CTD PMID:31636367 lead(2+) affects expression ISO RGD:1320055 6480464 Lead affects the expression of ANK1 mRNA CTD PMID:28903495 lead(2+) affects methylation ISO RGD:1320055 6480464 Lead affects the methylation of ANK1 gene CTD PMID:31636367 lipopolysaccharide decreases expression ISO RGD:1320055 6480464 Lipopolysaccharides results in decreased expression of ANK1 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:1320055 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ANK1 mRNA CTD PMID:35811015 mercury atom decreases expression ISO RGD:1320055 6480464 Mercury results in decreased expression of ANK1 mRNA CTD PMID:19937285 mercury dibromide increases expression ISO RGD:1320055 6480464 mercuric bromide results in increased expression of ANK1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1320055 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANK1 mRNA CTD PMID:27188386 mercury(0) decreases expression ISO RGD:1320055 6480464 Mercury results in decreased expression of ANK1 mRNA CTD PMID:19937285 methapyrilene affects methylation ISO RGD:1320055 6480464 Methapyrilene affects the methylation of ANK1 intron CTD PMID:30157460 mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of ANK1 mRNA CTD PMID:22401849 O-methyleugenol increases expression ISO RGD:1320055 6480464 methyleugenol results in increased expression of ANK1 mRNA CTD PMID:32234424 oxaliplatin multiple interactions ISO RGD:1309620 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ANK1 mRNA, [Topotecan co-treated with oxaliplatin] results in decreased expression of ANK1 mRNA CTD PMID:25729387 oxaliplatin decreases expression ISO RGD:1309620 6480464 oxaliplatin results in decreased expression of ANK1 mRNA CTD PMID:25729387 p-chloromercuribenzoic acid increases expression ISO RGD:1320055 6480464 p-Chloromercuribenzoic Acid results in increased expression of ANK1 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1320055 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANK1 mRNA CTD PMID:27188386 paracetamol increases expression ISO RGD:1309620 6480464 Acetaminophen results in increased expression of ANK1 mRNA CTD PMID:33387578 PCB138 multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 phenylmercury acetate increases expression ISO RGD:1320055 6480464 Phenylmercuric Acetate results in increased expression of ANK1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1320055 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANK1 mRNA CTD PMID:27188386 pioglitazone multiple interactions EXP 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ANK1 mRNA CTD PMID:27935865 rotenone decreases expression ISO RGD:1309620 6480464 Rotenone results in decreased expression of ANK1 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1320055 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ANK1 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1320055 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of ANK1 mRNA CTD PMID:21795629 sodium arsenite decreases methylation EXP 6480464 sodium arsenite results in decreased methylation of ANK1 gene CTD PMID:32068019 sodium arsenite affects expression ISO RGD:1320055 6480464 sodium arsenite affects the expression of ANK1 mRNA CTD PMID:34032870 sodium arsenite affects methylation ISO RGD:1320055 6480464 sodium arsenite affects the methylation of ANK1 gene CTD PMID:28589171 sunitinib decreases expression ISO RGD:1320055 6480464 Sunitinib results in decreased expression of ANK1 mRNA CTD PMID:31533062 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of ANK1 mRNA CTD PMID:17555576 testosterone increases expression ISO RGD:1320055 6480464 Testosterone results in increased expression of ANK1 mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:1320055 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ANK1 mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:1309620 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of ANK1 mRNA] CTD PMID:20032058 testosterone enanthate affects expression ISO RGD:1320055 6480464 testosterone enanthate affects the expression of ANK1 mRNA CTD PMID:17440010 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of ANK1 mRNA CTD PMID:23557971 topotecan multiple interactions ISO RGD:1309620 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ANK1 mRNA, [Topotecan co-treated with oxaliplatin] results in decreased expression of ANK1 mRNA CTD PMID:25729387 topotecan decreases expression ISO RGD:1309620 6480464 Topotecan results in decreased expression of ANK1 mRNA CTD PMID:25729387 trichloroethene increases expression ISO RGD:1309620 6480464 Trichloroethylene results in increased expression of ANK1 mRNA CTD PMID:33387578 valproic acid affects expression ISO RGD:1320055 6480464 Valproic Acid affects the expression of ANK1 mRNA CTD PMID:25979313 valproic acid affects splicing ISO RGD:1309620 6480464 Valproic Acid affects the splicing of ANK1 mRNA CTD PMID:29427782